{"id":"https://openalex.org/W1999727693","doi":"https://doi.org/10.1016/s0924-977x(12)70622-3","title":"P.6.c.002 Naltrexone for opioid dependence: oral, implantable, and injectable","display_name":"P.6.c.002 Naltrexone for opioid dependence: oral, implantable, and injectable","publication_year":2012,"publication_date":"2012-10-01","ids":{"openalex":"https://openalex.org/W1999727693","doi":"https://doi.org/10.1016/s0924-977x(12)70622-3","mag":"1999727693"},"language":"en","primary_location":{"id":"doi:10.1016/s0924-977x(12)70622-3","doi":"https://doi.org/10.1016/s0924-977x(12)70622-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-977x(12)70622-3","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021781906","display_name":"Evgeny M. Krupitsky","orcid":"https://orcid.org/0000-0002-0529-4525","observed_orcids":["https://orcid.org/0000-0002-0529-4525"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Krupitsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028959450","display_name":"Edwin E. Zvartau","orcid":"https://orcid.org/0000-0002-3597-7482","observed_orcids":["https://orcid.org/0000-0002-3597-7482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Zvartau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022919303","display_name":"Elena A. Blokhina","orcid":"https://orcid.org/0000-0001-5811-9897","observed_orcids":["https://orcid.org/0000-0001-5811-9897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Blokhina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025565501","display_name":"Elena V. Verbitskaya","orcid":"https://orcid.org/0000-0003-3770-993X","observed_orcids":["https://orcid.org/0000-0003-3770-993X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Verbitskaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027721711","display_name":"G. Woody","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Woody","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.14130549,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":"S399","last_page":"S400"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oral-naltrexone","display_name":"oral naltrexone","score":0.824999988079071},{"id":"https://openalex.org/keywords/injectable-naltrexone","display_name":"injectable naltrexone","score":0.9879999756813049},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.6700000166893005},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.9654155969619751},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6391991376876831},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5573291182518005},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4012952446937561},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.368768572807312},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24720877408981323},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.029469311237335205}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0924-977x(12)70622-3","doi":"https://doi.org/10.1016/s0924-977x(12)70622-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-977x(12)70622-3","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2055157261","https://openalex.org/W4245242751","https://openalex.org/W2018631669","https://openalex.org/W2334790337","https://openalex.org/W2042887435","https://openalex.org/W2548992226","https://openalex.org/W2084428395","https://openalex.org/W2330999140","https://openalex.org/W4291207699","https://openalex.org/W2031721712"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}